Strides Arcolab receives USFDA approval for Buspirone tablets

Strides Arcolab has received approval from United State Food & Drug Administration for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg.

Strides Arcolab Ltd has informed BSE regarding a Press Release dated August 26, 2014 titled "Strides Arcolab receives US FDA approval for Buspirone Tablets". Strides Arcolab has received approval from United State Food & Drug Administration for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg.Source : BSE

Read all announcements in Strides Arcolab

To read the full report click here

Anda sedang membaca artikel tentang

Strides Arcolab receives USFDA approval for Buspirone tablets

Dengan url

http://sehatgayahidup.blogspot.com/2014/08/strides-arcolab-receives-usfda-approval.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Strides Arcolab receives USFDA approval for Buspirone tablets

namun jangan lupa untuk meletakkan link

Strides Arcolab receives USFDA approval for Buspirone tablets

sebagai sumbernya